R-CHOP Alternating with R-DHAP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen that alternates rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with rituximab, dexamethasone, high-dose cytarabine and cisplatin (R-DHAP), and can be used in the treatment of mantle cell lymphoma.

**Synonyms:** - Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine Alternating with Rituximab Plus Cisplatin/Cytarabine/Dexamethasone - Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine-Rituximab/Cisplatin/Cytarabine/Dexamethasone - R-CHOP Alternating with R-DHAP - R-CHOP/R-DHAP - R-CHOP/R-DHAP - R-CHOP/R-DHAP (rituximab-abbs) - R-CHOP/R-DHAP (rituximab-arrx) - R-CHOP/R-DHAP (rituximab-blit) - R-CHOP/R-DHAP (rituximab-pvvr) - R-CHOP/R-DHAP (rituximab-rite) - R-CHOP/R-DHAP (rituximab-rixa) - R-CHOP/R-DHAP (rituximab-rixi) - R-CHOP/R-DHAP Regimen